Post-authorisation safety study of the incidence rate of medication errors before and after the discontinuation of the lower strength vials for Pharmalgen (NI-PH-X-01)

21/09/2018
02/07/2024
EU PAS number:
EUPAS25639
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

PASS protocol Pharmalgen_final

English (710.18 KB - PDF) View document
Study results
Study results

Pharmalgen PASS summary_final

English (24.84 KB - PDF) View document
Study report
Other information